Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Russell, Beth"'
Autor:
Iya AM; Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria., Beyer K; Translational Oncology and Urology Research, King's College London, London, UK., Kotecha P; Translational Oncology and Urology Research, King's College London, London, UK., Kibaru J; Translational Oncology and Urology Research, King's College London, London, UK., Abdullahi M; Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria.; Urology, Bayero University College of Health Sciences, Kano, Nigeria., Alhassan SU; Urology Unit, Aminu Kano Teaching Hospital, Kano, Nigeria., Mustapha MI; Oncology Unit, Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria., Ahmad A; Pathology, Aminu Kano Teaching Hospital, Kano, Nigeria., Lawal Y; Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria., Rabiu Ibrahim J; Community Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria., Aminu A; Microbiology, Aminu Kano Teaching Hospital, Kano, Nigeria., Abubakar A; Pharmacy, Aminu Kano Teaching Hospital, Kano, Nigeria., Saleh A; Nursing department, Aminu Kano Teaching Hospital, Kano, Nigeria., Bryan RT; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK., Russell B; Translational Oncology and Urology Research, King's College London, London, UK beth.russell@kcl.ac.uk.
Publikováno v:
BMJ open [BMJ Open] 2022 Mar 08; Vol. 12 (3), pp. e049241. Date of Electronic Publication: 2022 Mar 08.
Autor:
Russell B; Translational Oncology and Urology Research, King's College London, London, UK., Liedberg F; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Institution of Translational Medicine, Lund University, Malmö, Sweden., Hagberg O; Institution of Translational Medicine, Lund University, Malmö, Sweden., Ullén A; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Söderkvist K; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Ströck V; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Aljabery F; Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden., Gårdmark T; Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden., Jerlström T; Department of Urology, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden., Sherif A; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Holmberg L; Translational Oncology and Urology Research, King's College London, London, UK.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Bryan RT; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK., Enting D; Department of Uro-Oncology, Guy's Hospital, Guy's St Thomas NHS Foundation Trust, London, United Kingdom., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK.
Publikováno v:
Scandinavian journal of urology [Scand J Urol] 2022 Feb; Vol. 56 (1), pp. 27-33. Date of Electronic Publication: 2021 Nov 13.
Autor:
Spencer-Bowdage S; Action Bladder Cancer UK, Tetbury, UK., Russell B; Translational Oncology and Urology Research, King's College London, London, UK., Rigby J; Action Bladder Cancer UK, Tetbury, UK., O'Kelly J; Action Bladder Cancer UK, Tetbury, UK., Kelly P; Action Bladder Cancer UK, Tetbury, UK., Page M; Action Bladder Cancer UK, Tetbury, UK., Raw C; Action Bladder Cancer UK, Tetbury, UK., Allchorne P; Action Bladder Cancer UK, Tetbury, UK.; Barts Health NHS Trust, London, UK., Harper P; Action Bladder Cancer UK, Tetbury, UK.; Leaders in Oncology Care, London, UK., Crew J; Action Bladder Cancer UK, Tetbury, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Kockelbergh R; Action Bladder Cancer UK, Tetbury, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK.; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Knight A; Action Bladder Cancer UK, Tetbury, UK.; World Bladder Cancer Patient Coalition, Brussels, Belgium., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK., Bryan RT; Action Bladder Cancer UK, Tetbury, UK.; Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Publikováno v:
BJU international [BJU Int] 2021 Feb; Vol. 127 (2), pp. 179-181. Date of Electronic Publication: 2020 Nov 16.
Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research?
Autor:
Kibaru J; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK joyce.w.kibaru@kcl.ac.uk., Kotecha P; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK., Iya AM; Urology Unit, Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria., Russell B; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK., Abdullahi M; Urology Unit, Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria., Alhassan SU; Urology Unit, Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria., Mustapha MI; Clinical and Radiation Oncology Unit, Radiology Department, Aminu Kano Teaching Hospital, Kano, Nigeria., Bryan RT; Bladder Cancer Group, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK., Van Hemelrijck M; Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research, King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Jan 31; Vol. 11 (1), pp. e041894. Date of Electronic Publication: 2021 Jan 31.
Autor:
Bessa A; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom., Rammant E; Department of Radiation Oncology, Ghent University, Ghent, Belgium., Enting D; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom.; Dept. of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Bryan RT; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Shamim Khan M; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Malde S; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Nair R; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Thurairaja R; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Cahill F; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom., Amery S; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Smith S; Dept. of Psychology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Ahmed K; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Russell B; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom., Moss C; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom., Chatterton K; Bladder Cancer Research Centre, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Biobank Research, Umeå University, Umeå, Sweden., Van Hemelrijck M; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2021 Jan 28; Vol. 16 (1), pp. e0243136. Date of Electronic Publication: 2021 Jan 28 (Print Publication: 2021).
Autor:
Bessa A; King's College London, London, UK., Bosco C; King's College London, London, UK., Cahill F; King's College London, London, UK., Russell B; King's College London, London, UK., Fox L; King's College London, London, UK., Moss C; King's College London, London, UK., Wylie H; King's College London, London, UK., Haire A; King's College London, London, UK., Green S; King's College London, London, UK., Enting D; King's College London, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK., Khan S; Guy's and St Thomas' NHS Foundation Trust, London, UK., Nair R; Guy's and St Thomas' NHS Foundation Trust, London, UK., Thurairaja R; Guy's and St Thomas' NHS Foundation Trust, London, UK., Chatterton K; Guy's and St Thomas' NHS Foundation Trust, London, UK., Amery S; Guy's and St Thomas' NHS Foundation Trust, London, UK., Peat N; Guy's and St Thomas' NHS Foundation Trust, London, UK., Smith S; Guy's and St Thomas' NHS Foundation Trust, London, UK., Spear S; Guy's and St Thomas' NHS Foundation Trust, London, UK., Bryan RT; University of Birmingham, Birmingham, UK., Frodsham L; Guy's and St Thomas' NHS Foundation Trust, London, UK., Burke D; Guy's and St Thomas' NHS Foundation Trust, London, UK., Rigby J; Action Bladder Cancer, Gloucestershire, UK., Makaroff L; Action Bladder Cancer, Gloucestershire, UK., Kelly P; Action Bladder Cancer, Gloucestershire, UK., Costin M; Fight Bladder Cancer, Oxfordshire, UK., Häggström C; Uppsala University, Uppsala, Sweden.; Umeå University, Umeå, Sweden., Van Hemelrijck M; King's College London, London, UK.
Publikováno v:
Inquiry : a journal of medical care organization, provision and financing [Inquiry] 2021 Jan-Dec; Vol. 58, pp. 469580211030217.
Autor:
Russell B; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Hemelrijck MV; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Gårdmark T; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Sweden., Holmberg L; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Kumar P; The Royal Marsden NHS Foundation Trust, London, UK., Bellavia A; Department of Environmental Health, Harvard T.H. Chan School of Public Health., Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Biobank Research, Umeå University, Umeå, Sweden.
Publikováno v:
Cancer medicine [Cancer Med] 2020 Oct; Vol. 9 (20), pp. 7477-7487. Date of Electronic Publication: 2020 Aug 26.
Autor:
Russell B; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Electronic address: beth.russell@kcl.ac.uk., Liedberg F; Department of Urology, Skåne University Hospital, Malmö, Sweden; Institution of Translational Medicine, Lund University, Malmö, Sweden., Khan MS; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Nair R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Thurairaja R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Malde S; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Kumar P; The Royal Marsden NHS Foundation Trust, London, UK., Bryan RT; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Van Hemelrijck M; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2020 Apr; Vol. 3 (2), pp. 239-249. Date of Electronic Publication: 2019 Oct 23.
Autor:
Mehrotra S; Translational Oncology and Urology Research, King's College London, London, UK., Rowland M; Translational Oncology and Urology Research, King's College London, London, UK., Zhang H; Translational Oncology and Urology Research, King's College London, London, UK., Russell B; Translational Oncology and Urology Research, King's College London, London, UK., Fox L; Translational Oncology and Urology Research, King's College London, London, UK., Beyer K; Translational Oncology and Urology Research, King's College London, London, UK., Rammant E; Human structure and repair, Ghent University, Ghent, Belgium., Peat N; Physiotherapy Dept - Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK mieke.vanhemelrijck@kcl.ac.uk., Bosco C; Translational Oncology and Urology Research, King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2019 Nov 12; Vol. 9 (11), pp. e033518. Date of Electronic Publication: 2019 Nov 12.
The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy.
Autor:
Stroman L; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Nair R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Russell B; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Malik N; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Desai A; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Chandra A; Department of Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Thurairaja R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Khan MS; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Malde S; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Publikováno v:
BJU international [BJU Int] 2019 Sep; Vol. 124 (3), pp. 418-423. Date of Electronic Publication: 2019 Mar 04.